Charles River Labs Intl buy Citigroup Inc.
Start price
09.07.25
/
50%
€135.75
Target price
09.07.26
€170.62
Performance (%)
12.38%
Price
09.03.26
€152.55
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 12.38%. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | -1.134% | -1.134% |
| iShares Core DAX® | -2,53 % | -5,19 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % |
| iShares S&P 500 | -0,80 % | 0,16 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $200.00 price target on the stock, up previously from $150.00.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€175.45
01.10.24
01.10.24
€158.03
01.10.25
01.10.25
-17.50%
02.10.25
02.10.25
